Assistance Publique - Hôpitaux de Paris: Carcinoma trials

The registry lists 27 Carcinoma studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 4Phase 4 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated with Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National CohortRecruitingNCT06334965Not applicable
• Immunotherapy in Upper Tract Urothelial CarcinomaNot yet recruitingNCT06113367
• Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)Not yet recruitingNCT06068088
• Cohort of Patients With Hepatocellular Carcinoma or CholangiocarcinomaRecruitingNCT04340986
• Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular CarcinomaActive, not recruitingNCT05901194Phase 1/2
• Identification of Image Phenotypes to Predict Recurrence After Resection of Hepatocellular CarcinomaCompletedNCT05235490
• Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"CompletedNCT04823754
• Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular CarcinomaActive, not recruitingNCT04791735Not applicable
• Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCCCompletedNCT04391348Not applicable
• Interest of the Intervention of a Nurse Coordinator in Complex Care PathwayStatus unknownNCT04209491
• Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized StudyCompletedNCT04065139Phase 2
• Perfusion and Dual Energy Computer Tomography in Hepatocellular CarcinomaStatus unknownNCT03754192Not applicable
• Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the SkinCompletedNCT02883556Phase 2
• Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and CholangiocarcinomaCompletedNCT02730611
• PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic AgentsTerminatedNCT02325349Phase 2
• Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
• Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer PatientsCompletedNCT02025062Not applicable
• SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular CarcinomaCompletedNCT01482442Phase 3
• Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
• Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01198704
• Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular TechniqueCompletedNCT01008657Not applicable
• Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
• Human Papillomavirus and Oropharynx CarcinomaStatus unknownNCT00918710
• Impact of Predicting Anti-angiogenic Response in mRCC Using Functional ImagingCompletedNCT00842790
• Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid CancerTerminatedNCT00647140Phase 2
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
• Screening of Hepatocellular Carcinoma in Patients With Compensated CirrhosisCompletedNCT00190385Phase 3